APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Paroxetine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Paroxetine Market Analysis and Forecast 2026-2032

Report ID 174022440222 December 2025199 pages

Choose your research edition.

Industry ResearchParoxetine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Paroxetine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Paroxetine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Paroxetine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Paroxetine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Paroxetine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Paroxetine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Paroxetine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Paroxetine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Paroxetine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Paroxetine include Teva, Sun Pharmaceutical, Mylan, Aurobindo, Sebela Pharmaceuticals, Neurocon Inc, Lupin, Lifegenix and Lannett Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Paroxetine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Paroxetine, also provides the sales of main regions and countries. Of the upcoming market potential for Paroxetine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Paroxetine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Paroxetine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Paroxetine sales, projected growth trends, production technology, application and end-user industry.

Paroxetine Segment by Company

Teva

Sun Pharmaceutical

Mylan

Aurobindo

Sebela Pharmaceuticals

Neurocon Inc

Lupin

Lifegenix

Lannett Company

Jubilant Pharma

Apotex

Paroxetine Segment by Type

Paroxetine Hydrochloride Drug

Paroxetine Mesylate Drug

Paroxetine Segment by Application

Depression

Social anxiety disorder

Panic disorder

Others

Paroxetine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paroxetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Paroxetine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paroxetine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Paroxetine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Paroxetine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Paroxetine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Paroxetine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Paroxetine Hydrochloride Drug Major Manufacturers Table 3. Paroxetine Mesylate Drug Major Manufacturers Table 4. Global Paroxetine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Depression Major Manufacturers Table 6. Social anxiety disorder Major Manufacturers Table 7. Panic disorder Major Manufacturers Table 8. Others Major Manufacturers Table 9. Paroxetine Industry Trends Table 10. Paroxetine Industry Drivers Table 11. Paroxetine Industry Opportunities and Challenges Table 12. Paroxetine Industry Restraints Table 13. Global Paroxetine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Paroxetine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Paroxetine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Paroxetine Revenue Market Share by Region (2021-2026) Table 17. Global Paroxetine Revenue Market Share by Region (2027-2032) Table 18. Global Paroxetine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Paroxetine Sales by Region (2021-2026) & (k units) Table 20. Global Paroxetine Sales by Region (2027-2032) & (k units) Table 21. Global Paroxetine Sales Market Share by Region (2021-2026) Table 22. Global Paroxetine Sales Market Share by Region (2027-2032) Table 23. Global Paroxetine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Paroxetine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Paroxetine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Paroxetine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Paroxetine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Paroxetine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Paroxetine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Paroxetine Manufacturers, Product Type & Application Table 31. Global Paroxetine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Paroxetine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Paroxetine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Paroxetine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Paroxetine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Paroxetine Revenue Market Share by Type (2021-2026) Table 38. Global Paroxetine Revenue Market Share by Type (2027-2032) Table 39. Global Paroxetine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Paroxetine Sales by Type (2021-2026) & (k units) Table 41. Global Paroxetine Sales by Type (2027-2032) & (k units) Table 42. Global Paroxetine Sales Market Share by Type (2021-2026) Table 43. Global Paroxetine Sales Market Share by Type (2027-2032) Table 44. Global Paroxetine Price by Type (2021-2026) & (US$/unit) Table 45. Global Paroxetine Price by Type (2027-2032) & (US$/unit) Table 46. Global Paroxetine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Paroxetine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Paroxetine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Paroxetine Revenue Market Share by Application (2021-2026) Table 50. Global Paroxetine Revenue Market Share by Application (2027-2032) Table 51. Global Paroxetine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Paroxetine Sales by Application (2021-2026) & (k units) Table 53. Global Paroxetine Sales by Application (2027-2032) & (k units) Table 54. Global Paroxetine Sales Market Share by Application (2021-2026) Table 55. Global Paroxetine Sales Market Share by Application (2027-2032) Table 56. Global Paroxetine Price by Application (2021-2026) & (US$/unit) Table 57. Global Paroxetine Price by Application (2027-2032) & (US$/unit) Table 58. Teva Company Information Table 59. Teva Business Overview Table 60. Teva Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Teva Paroxetine Product Portfolio Table 62. Teva Recent Development Table 63. Sun Pharmaceutical Company Information Table 64. Sun Pharmaceutical Business Overview Table 65. Sun Pharmaceutical Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Sun Pharmaceutical Paroxetine Product Portfolio Table 67. Sun Pharmaceutical Recent Development Table 68. Mylan Company Information Table 69. Mylan Business Overview Table 70. Mylan Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Mylan Paroxetine Product Portfolio Table 72. Mylan Recent Development Table 73. Aurobindo Company Information Table 74. Aurobindo Business Overview Table 75. Aurobindo Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Aurobindo Paroxetine Product Portfolio Table 77. Aurobindo Recent Development Table 78. Sebela Pharmaceuticals Company Information Table 79. Sebela Pharmaceuticals Business Overview Table 80. Sebela Pharmaceuticals Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Sebela Pharmaceuticals Paroxetine Product Portfolio Table 82. Sebela Pharmaceuticals Recent Development Table 83. Neurocon Inc Company Information Table 84. Neurocon Inc Business Overview Table 85. Neurocon Inc Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Neurocon Inc Paroxetine Product Portfolio Table 87. Neurocon Inc Recent Development Table 88. Lupin Company Information Table 89. Lupin Business Overview Table 90. Lupin Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Lupin Paroxetine Product Portfolio Table 92. Lupin Recent Development Table 93. Lifegenix Company Information Table 94. Lifegenix Business Overview Table 95. Lifegenix Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Lifegenix Paroxetine Product Portfolio Table 97. Lifegenix Recent Development Table 98. Lannett Company Company Information Table 99. Lannett Company Business Overview Table 100. Lannett Company Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Lannett Company Paroxetine Product Portfolio Table 102. Lannett Company Recent Development Table 103. Jubilant Pharma Company Information Table 104. Jubilant Pharma Business Overview Table 105. Jubilant Pharma Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Jubilant Pharma Paroxetine Product Portfolio Table 107. Jubilant Pharma Recent Development Table 108. Apotex Company Information Table 109. Apotex Business Overview Table 110. Apotex Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Apotex Paroxetine Product Portfolio Table 112. Apotex Recent Development Table 113. North America Paroxetine Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Paroxetine Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Paroxetine Sales by Type (2021-2026) & (k units) Table 116. North America Paroxetine Sales by Type (2027-2032) & (k units) Table 117. North America Paroxetine Sales Price by Type (2021-2026) & (US$/unit) Table 118. North America Paroxetine Sales Price by Type (2027-2032) & (US$/unit) Table 119. North America Paroxetine Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Paroxetine Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Paroxetine Sales by Application (2021-2026) & (k units) Table 122. North America Paroxetine Sales by Application (2027-2032) & (k units) Table 123. North America Paroxetine Sales Price by Application (2021-2026) & (US$/unit) Table 124. North America Paroxetine Sales Price by Application (2027-2032) & (US$/unit) Table 125. North America Paroxetine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Paroxetine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Paroxetine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Paroxetine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 129. North America Paroxetine Sales by Country (2021-2026) & (k units) Table 130. North America Paroxetine Sales by Country (2027-2032) & (k units) Table 131. North America Paroxetine Sales Price by Country (2021-2026) & (US$/unit) Table 132. North America Paroxetine Sales Price by Country (2027-2032) & (US$/unit) Table 133. United States Paroxetine Revenue (2021-2032) & (US$ Million) Table 134. Canada Paroxetine Revenue (2021-2032) & (US$ Million) Table 135. Mexico Paroxetine Revenue (2021-2032) & (US$ Million) Table 136. Europe Paroxetine Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Paroxetine Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Paroxetine Sales by Type (2021-2026) & (k units) Table 139. Europe Paroxetine Sales by Type (2027-2032) & (k units) Table 140. Europe Paroxetine Sales Price by Type (2021-2026) & (US$/unit) Table 141. Europe Paroxetine Sales Price by Type (2027-2032) & (US$/unit) Table 142. Europe Paroxetine Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe Paroxetine Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe Paroxetine Sales by Application (2021-2026) & (k units) Table 145. Europe Paroxetine Sales by Application (2027-2032) & (k units) Table 146. Europe Paroxetine Sales Price by Application (2021-2026) & (US$/unit) Table 147. Europe Paroxetine Sales Price by Application (2027-2032) & (US$/unit) Table 148. Europe Paroxetine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Paroxetine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Europe Paroxetine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Europe Paroxetine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 152. Europe Paroxetine Sales by Country (2021-2026) & (k units) Table 153. Europe Paroxetine Sales by Country (2027-2032) & (k units) Table 154. Europe Paroxetine Sales Price by Country (2021-2026) & (US$/unit) Table 155. Europe Paroxetine Sales Price by Country (2027-2032) & (US$/unit) Table 156. Germany Paroxetine Revenue (2021-2032) & (US$ Million) Table 157. France Paroxetine Revenue (2021-2032) & (US$ Million) Table 158. U.K. Paroxetine Revenue (2021-2032) & (US$ Million) Table 159. Italy Paroxetine Revenue (2021-2032) & (US$ Million) Table 160. Russia Paroxetine Revenue (2021-2032) & (US$ Million) Table 161. Spain Paroxetine Revenue (2021-2032) & (US$ Million) Table 162. Netherlands Paroxetine Revenue (2021-2032) & (US$ Million) Table 163. Switzerland Paroxetine Revenue (2021-2032) & (US$ Million) Table 164. Sweden Paroxetine Revenue (2021-2032) & (US$ Million) Table 165. Poland Paroxetine Revenue (2021-2032) & (US$ Million) Table 166. China Paroxetine Revenue by Type (2021-2026) & (US$ Million) Table 167. China Paroxetine Revenue by Type (2027-2032) & (US$ Million) Table 168. China Paroxetine Sales by Type (2021-2026) & (k units) Table 169. China Paroxetine Sales by Type (2027-2032) & (k units) Table 170. China Paroxetine Sales Price by Type (2021-2026) & (US$/unit) Table 171. China Paroxetine Sales Price by Type (2027-2032) & (US$/unit) Table 172. China Paroxetine Revenue by Application (2021-2026) & (US$ Million) Table 173. China Paroxetine Revenue by Application (2027-2032) & (US$ Million) Table 174. China Paroxetine Sales by Application (2021-2026) & (k units) Table 175. China Paroxetine Sales by Application (2027-2032) & (k units) Table 176. China Paroxetine Sales Price by Application (2021-2026) & (US$/unit) Table 177. China Paroxetine Sales Price by Application (2027-2032) & (US$/unit) Table 178. Asia Paroxetine Revenue by Type (2021-2026) & (US$ Million) Table 179. Asia Paroxetine Revenue by Type (2027-2032) & (US$ Million) Table 180. Asia Paroxetine Sales by Type (2021-2026) & (k units) Table 181. Asia Paroxetine Sales by Type (2027-2032) & (k units) Table 182. Asia Paroxetine Sales Price by Type (2021-2026) & (US$/unit) Table 183. Asia Paroxetine Sales Price by Type (2027-2032) & (US$/unit) Table 184. Asia Paroxetine Revenue by Application (2021-2026) & (US$ Million) Table 185. Asia Paroxetine Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia Paroxetine Sales by Application (2021-2026) & (k units) Table 187. Asia Paroxetine Sales by Application (2027-2032) & (k units) Table 188. Asia Paroxetine Sales Price by Application (2021-2026) & (US$/unit) Table 189. Asia Paroxetine Sales Price by Application (2027-2032) & (US$/unit) Table 190. Asia Paroxetine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Asia Paroxetine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. Asia Paroxetine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. Asia Paroxetine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 194. Asia Paroxetine Sales by Country (2021-2026) & (k units) Table 195. Asia Paroxetine Sales by Country (2027-2032) & (k units) Table 196. Asia Paroxetine Sales Price by Country (2021-2026) & (US$/unit) Table 197. Asia Paroxetine Sales Price by Country (2027-2032) & (US$/unit) Table 198. Japan Paroxetine Revenue (2021-2032) & (US$ Million) Table 199. South Korea Paroxetine Revenue (2021-2032) & (US$ Million) Table 200. India Paroxetine Revenue (2021-2032) & (US$ Million) Table 201. Australia Paroxetine Revenue (2021-2032) & (US$ Million) Table 202. Taiwan Paroxetine Revenue (2021-2032) & (US$ Million) Table 203. Southeast Asia Paroxetine Revenue (2021-2032) & (US$ Million) Table 204. SAMEA Paroxetine Revenue by Type (2021-2026) & (US$ Million) Table 205. SAMEA Paroxetine Revenue by Type (2027-2032) & (US$ Million) Table 206. SAMEA Paroxetine Sales by Type (2021-2026) & (k units) Table 207. SAMEA Paroxetine Sales by Type (2027-2032) & (k units) Table 208. SAMEA Paroxetine Sales Price by Type (2021-2026) & (US$/unit) Table 209. SAMEA Paroxetine Sales Price by Type (2027-2032) & (US$/unit) Table 210. SAMEA Paroxetine Revenue by Application (2021-2026) & (US$ Million) Table 211. SAMEA Paroxetine Revenue by Application (2027-2032) & (US$ Million) Table 212. SAMEA Paroxetine Sales by Application (2021-2026) & (k units) Table 213. SAMEA Paroxetine Sales by Application (2027-2032) & (k units) Table 214. SAMEA Paroxetine Sales Price by Application (2021-2026) & (US$/unit) Table 215. SAMEA Paroxetine Sales Price by Application (2027-2032) & (US$/unit) Table 216. SAMEA Paroxetine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. SAMEA Paroxetine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. SAMEA Paroxetine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. SAMEA Paroxetine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 220. SAMEA Paroxetine Sales by Country (2021-2026) & (k units) Table 221. SAMEA Paroxetine Sales by Country (2027-2032) & (k units) Table 222. SAMEA Paroxetine Sales Price by Country (2021-2026) & (US$/unit) Table 223. SAMEA Paroxetine Sales Price by Country (2027-2032) & (US$/unit) Table 224. Brazil Paroxetine Revenue (2021-2032) & (US$ Million) Table 225. Argentina Paroxetine Revenue (2021-2032) & (US$ Million) Table 226. Chile Paroxetine Revenue (2021-2032) & (US$ Million) Table 227. Colombia Paroxetine Revenue (2021-2032) & (US$ Million) Table 228. Peru Paroxetine Revenue (2021-2032) & (US$ Million) Table 229. Saudi Arabia Paroxetine Revenue (2021-2032) & (US$ Million) Table 230. Israel Paroxetine Revenue (2021-2032) & (US$ Million) Table 231. UAE Paroxetine Revenue (2021-2032) & (US$ Million) Table 232. Turkey Paroxetine Revenue (2021-2032) & (US$ Million) Table 233. Iran Paroxetine Revenue (2021-2032) & (US$ Million) Table 234. Egypt Paroxetine Revenue (2021-2032) & (US$ Million) Table 235. Key Raw Materials Table 236. Raw Materials Key Suppliers Table 237. Paroxetine Distributors List Table 238. Paroxetine Customers List Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. Paroxetine Image Figure 2. Global Paroxetine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Paroxetine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Paroxetine Hydrochloride Drug Image Figure 5. Paroxetine Mesylate Drug Image Figure 6. Global Paroxetine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Paroxetine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Depression Image Figure 9. Social anxiety disorder Image Figure 10. Panic disorder Image Figure 11. Others Image Figure 12. Global Paroxetine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Paroxetine Revenue (2021-2032) & (US$ Million) Figure 14. Global Paroxetine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Paroxetine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Paroxetine Revenue Market Share by Region (2021-2032) Figure 17. Global Paroxetine Sales (2021-2032) & (k units) Figure 18. Global Paroxetine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Paroxetine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Paroxetine Sales YoY (2021-2032) & (k units) Figure 21. Europe Paroxetine Sales YoY (2021-2032) & (k units) Figure 22. China Paroxetine Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Paroxetine Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Paroxetine Sales YoY (2021-2032) & (k units) Figure 25. Global Paroxetine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Paroxetine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Paroxetine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Paroxetine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Paroxetine Revenue Market Share by Type (2021-2032) Figure 31. Global Paroxetine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Paroxetine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Paroxetine Sales Market Share by Type (2021-2032) Figure 34. Global Paroxetine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Paroxetine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Paroxetine Revenue Market Share by Application (2021-2032) Figure 37. Global Paroxetine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Paroxetine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Paroxetine Sales Market Share by Application (2021-2032) Figure 40. North America Paroxetine Revenue Share by Type (2021-2032) Figure 41. North America Paroxetine Sales Share by Type (2021-2032) Figure 42. North America Paroxetine Revenue Share by Application (2021-2032) Figure 43. North America Paroxetine Sales Share by Application (2021-2032) Figure 44. North America Paroxetine Revenue Share by Country (2021-2032) Figure 45. North America Paroxetine Sales Share by Country (2021-2032) Figure 46. Europe Paroxetine Revenue Share by Type (2021-2032) Figure 47. Europe Paroxetine Sales Share by Type (2021-2032) Figure 48. Europe Paroxetine Revenue Share by Application (2021-2032) Figure 49. Europe Paroxetine Sales Share by Application (2021-2032) Figure 50. Europe Paroxetine Revenue Share by Country (2021-2032) Figure 51. Europe Paroxetine Sales Share by Country (2021-2032) Figure 52. China Paroxetine Revenue Share by Type (2021-2032) Figure 53. China Paroxetine Sales Share by Type (2021-2032) Figure 54. China Paroxetine Revenue Share by Application (2021-2032) Figure 55. China Paroxetine Sales Share by Application (2021-2032) Figure 56. Asia Paroxetine Revenue Share by Type (2021-2032) Figure 57. Asia Paroxetine Sales Share by Type (2021-2032) Figure 58. Asia Paroxetine Revenue Share by Application (2021-2032) Figure 59. Asia Paroxetine Sales Share by Application (2021-2032) Figure 60. Asia Paroxetine Revenue Share by Country (2021-2032) Figure 61. Asia Paroxetine Sales Share by Country (2021-2032) Figure 62. SAMEA Paroxetine Revenue Share by Type (2021-2032) Figure 63. SAMEA Paroxetine Sales Share by Type (2021-2032) Figure 64. SAMEA Paroxetine Revenue Share by Application (2021-2032) Figure 65. SAMEA Paroxetine Sales Share by Application (2021-2032) Figure 66. SAMEA Paroxetine Revenue Share by Country (2021-2032) Figure 67. SAMEA Paroxetine Sales Share by Country (2021-2032) Figure 68. Paroxetine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Paroxetine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Paroxetine Hydrochloride Drug
  • Paroxetine Mesylate Drug
Applications
  • Depression
  • Social anxiety disorder
  • Panic disorder
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Mylan
  • Aurobindo
  • Sebela Pharmaceuticals
  • Neurocon Inc
  • Lupin
  • Lifegenix
  • Lannett Company
  • Jubilant Pharma
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Paroxetine Market by Type
  3. 1.2.1 Global Paroxetine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Paroxetine Hydrochloride Drug
  5. 1.2.3 Paroxetine Mesylate Drug
  6. 1.3 Paroxetine Market by Application
  7. 1.3.1 Global Paroxetine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Depression
  9. 1.3.3 Social anxiety disorder
  10. 1.3.4 Panic disorder
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Paroxetine Market Dynamics
  1. 2.1 Paroxetine Industry Trends
  2. 2.2 Paroxetine Industry Drivers
  3. 2.3 Paroxetine Industry Opportunities and Challenges
  4. 2.4 Paroxetine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Paroxetine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Paroxetine Revenue by Region
  3. 3.2.1 Global Paroxetine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Paroxetine Revenue by Region (2021-2026)
  5. 3.2.3 Global Paroxetine Revenue by Region (2027-2032)
  6. 3.2.4 Global Paroxetine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Paroxetine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Paroxetine Sales by Region
  9. 3.4.1 Global Paroxetine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Paroxetine Sales by Region (2021-2026)
  11. 3.4.3 Global Paroxetine Sales by Region (2027-2032)
  12. 3.4.4 Global Paroxetine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Paroxetine Revenue by Manufacturers
  2. 4.1.1 Global Paroxetine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Paroxetine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Paroxetine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Paroxetine Sales by Manufacturers
  6. 4.2.1 Global Paroxetine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Paroxetine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Paroxetine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Paroxetine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Paroxetine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Paroxetine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Paroxetine Manufacturers, Product Type & Application
  13. 4.7 Global Paroxetine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Paroxetine Market CR5 and HHI
  16. 4.8.2 2025 Paroxetine Tier 1, Tier 2, and Tier 3
5 Paroxetine Market by Type
  1. 5.1 Global Paroxetine Revenue by Type
  2. 5.1.1 Global Paroxetine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Paroxetine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Paroxetine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Paroxetine Sales by Type
  6. 5.2.1 Global Paroxetine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Paroxetine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Paroxetine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Paroxetine Price by Type
6 Paroxetine Market by Application
  1. 6.1 Global Paroxetine Revenue by Application
  2. 6.1.1 Global Paroxetine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Paroxetine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Paroxetine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Paroxetine Sales by Application
  6. 6.2.1 Global Paroxetine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Paroxetine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Paroxetine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Paroxetine Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Paroxetine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Paroxetine Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Sun Pharmaceutical
  8. 7.2.1 Sun Pharmaceutical Company Information
  9. 7.2.2 Sun Pharmaceutical Business Overview
  10. 7.2.3 Sun Pharmaceutical Paroxetine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharmaceutical Paroxetine Product Portfolio
  12. 7.2.5 Sun Pharmaceutical Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Paroxetine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Paroxetine Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Aurobindo
  20. 7.4.1 Aurobindo Company Information
  21. 7.4.2 Aurobindo Business Overview
  22. 7.4.3 Aurobindo Paroxetine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Aurobindo Paroxetine Product Portfolio
  24. 7.4.5 Aurobindo Recent Developments
  25. 7.5 Sebela Pharmaceuticals
  26. 7.5.1 Sebela Pharmaceuticals Company Information
  27. 7.5.2 Sebela Pharmaceuticals Business Overview
  28. 7.5.3 Sebela Pharmaceuticals Paroxetine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sebela Pharmaceuticals Paroxetine Product Portfolio
  30. 7.5.5 Sebela Pharmaceuticals Recent Developments
  31. 7.6 Neurocon Inc
  32. 7.6.1 Neurocon Inc Company Information
  33. 7.6.2 Neurocon Inc Business Overview
  34. 7.6.3 Neurocon Inc Paroxetine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Neurocon Inc Paroxetine Product Portfolio
  36. 7.6.5 Neurocon Inc Recent Developments
  37. 7.7 Lupin
  38. 7.7.1 Lupin Company Information
  39. 7.7.2 Lupin Business Overview
  40. 7.7.3 Lupin Paroxetine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Lupin Paroxetine Product Portfolio
  42. 7.7.5 Lupin Recent Developments
  43. 7.8 Lifegenix
  44. 7.8.1 Lifegenix Company Information
  45. 7.8.2 Lifegenix Business Overview
  46. 7.8.3 Lifegenix Paroxetine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Lifegenix Paroxetine Product Portfolio
  48. 7.8.5 Lifegenix Recent Developments
  49. 7.9 Lannett Company
  50. 7.9.1 Lannett Company Company Information
  51. 7.9.2 Lannett Company Business Overview
  52. 7.9.3 Lannett Company Paroxetine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Lannett Company Paroxetine Product Portfolio
  54. 7.9.5 Lannett Company Recent Developments
  55. 7.10 Jubilant Pharma
  56. 7.10.1 Jubilant Pharma Company Information
  57. 7.10.2 Jubilant Pharma Business Overview
  58. 7.10.3 Jubilant Pharma Paroxetine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Jubilant Pharma Paroxetine Product Portfolio
  60. 7.10.5 Jubilant Pharma Recent Developments
  61. 7.11 Apotex
  62. 7.11.1 Apotex Company Information
  63. 7.11.2 Apotex Business Overview
  64. 7.11.3 Apotex Paroxetine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Apotex Paroxetine Product Portfolio
  66. 7.11.5 Apotex Recent Developments
8 North America
  1. 8.1 North America Paroxetine Market Size by Type
  2. 8.1.1 North America Paroxetine Revenue by Type (2021-2032)
  3. 8.1.2 North America Paroxetine Sales by Type (2021-2032)
  4. 8.1.3 North America Paroxetine Price by Type (2021-2032)
  5. 8.2 North America Paroxetine Market Size by Application
  6. 8.2.1 North America Paroxetine Revenue by Application (2021-2032)
  7. 8.2.2 North America Paroxetine Sales by Application (2021-2032)
  8. 8.2.3 North America Paroxetine Price by Application (2021-2032)
  9. 8.3 North America Paroxetine Market Size by Country
  10. 8.3.1 North America Paroxetine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Paroxetine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Paroxetine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Paroxetine Market Size by Type
  2. 9.1.1 Europe Paroxetine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Paroxetine Sales by Type (2021-2032)
  4. 9.1.3 Europe Paroxetine Price by Type (2021-2032)
  5. 9.2 Europe Paroxetine Market Size by Application
  6. 9.2.1 Europe Paroxetine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Paroxetine Sales by Application (2021-2032)
  8. 9.2.3 Europe Paroxetine Price by Application (2021-2032)
  9. 9.3 Europe Paroxetine Market Size by Country
  10. 9.3.1 Europe Paroxetine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Paroxetine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Paroxetine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Paroxetine Market Size by Type
  2. 10.1.1 China Paroxetine Revenue by Type (2021-2032)
  3. 10.1.2 China Paroxetine Sales by Type (2021-2032)
  4. 10.1.3 China Paroxetine Price by Type (2021-2032)
  5. 10.2 China Paroxetine Market Size by Application
  6. 10.2.1 China Paroxetine Revenue by Application (2021-2032)
  7. 10.2.2 China Paroxetine Sales by Application (2021-2032)
  8. 10.2.3 China Paroxetine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Paroxetine Market Size by Type
  2. 11.1.1 Asia Paroxetine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Paroxetine Sales by Type (2021-2032)
  4. 11.1.3 Asia Paroxetine Price by Type (2021-2032)
  5. 11.2 Asia Paroxetine Market Size by Application
  6. 11.2.1 Asia Paroxetine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Paroxetine Sales by Application (2021-2032)
  8. 11.2.3 Asia Paroxetine Price by Application (2021-2032)
  9. 11.3 Asia Paroxetine Market Size by Country
  10. 11.3.1 Asia Paroxetine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Paroxetine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Paroxetine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Paroxetine Market Size by Type
  2. 12.1.1 SAMEA Paroxetine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Paroxetine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Paroxetine Price by Type (2021-2032)
  5. 12.2 SAMEA Paroxetine Market Size by Application
  6. 12.2.1 SAMEA Paroxetine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Paroxetine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Paroxetine Price by Application (2021-2032)
  9. 12.3 SAMEA Paroxetine Market Size by Country
  10. 12.3.1 SAMEA Paroxetine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Paroxetine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Paroxetine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Paroxetine Value Chain Analysis
  2. 13.1.1 Paroxetine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Paroxetine Production Mode & Process
  6. 13.2 Paroxetine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Paroxetine Distributors
  9. 13.2.3 Paroxetine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst